Clinical Trials Browser

Interventional × Head and Neck Neoplasms × camrelizumab × Clear all

NCT04510818 2020-08-14

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)

Phase 1 Unknown

Head and Neck Neoplasms

NCT04405154 2020-05-28

A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer

Phase 2 Unknown

Carcinoma, Squamous Cell, Head and Neck Neoplasms